Jefferies Financial Group Inc. Innoviva, Inc. Transaction History

Jefferies Financial Group Inc.

  • $8.87 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$14.56 - $16.78 $160,160 - $184,580
11,000 Added 29.73%
48,000 $731,000
Q4 2023

Feb 13, 2024
BUY
$12.32 - $16.27 $455,840 - $601,990
37,000 New
37,000 $593,000
Q4 2022

Feb 14, 2023
BUY
$11.8 - $13.78 $158,497 - $185,092
13,432 New
13,432 $177,000

Others Institutions Holding INVA

# of Institutions
222
Shares Held
79.7M
Call Options Held
20K
Put Options Held
5.4K
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.35B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email